Ge Junbo
葛均波
Academician of the Chinese Academy of Sciences, Chief Physician, Professor, Doctoral Supervisor, and Director of Cardiology
Interventional cardiology for coronary artery disease, especially complex coronary intervention, chronic total occlusion, intravascular ultrasound-guided diagnosis and therapy, myocardial bridging, and coronary device innovation(冠心病介入诊疗，重点包括复杂冠脉介入、慢性完全闭塞病变、血管内超声指导下诊疗、心肌桥以及冠脉器械创新)
112+ career cases
(haodf.com)Leadership & Positions
- Director, Department of Cardiology, Zhongshan Hospital, Fudan University
- Director, Cardiac Catheterization Laboratory, Zhongshan Hospital, Fudan University
- Director, Shanghai Institute of Cardiovascular Diseases
- Director, Fudan University Stem Cell and Tissue Engineering Center
- Chief Scientist, Shanghai Parkway Hospital
- Former President, Asian Pacific Society of Interventional Cardiology
- Former Chair, Chinese Society of Cardiology
Medical School
Qingdao Medical College (1984)
Graduate
MD / Doctor of Medicine, University of Mainz Faculty of Medicine
Fellowships & Training
University of Mainz Faculty of Medicine — Cardiology advanced study and doctoral training (Germany)
University of Essen Faculty of Medicine — Postdoctoral research and intravascular ultrasound / interventional cardiology (Germany)
Languages
Notable Publications
Prognostic Value of Angiographic Microcirculatory Resistance After Coronary Intervention: Insights From the FAVOR III China Trial.
Journal of the American Heart Association (2026) — co-author
PubMed/DOITwelve-month angiographic and clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold and a metallic stent in patients with coronary artery disease.
International Journal of Cardiology (2019) — corresponding author
PubMed/DOIHealing score of the Xinsorb scaffold in the treatment of de novo lesions: 6-month imaging outcomes.
The International Journal of Cardiovascular Imaging (2018) — corresponding author
PubMed/DOIPioneering Contributions
- Identified the intravascular ultrasound 'half-moon sign' in myocardial bridging, materially improving recognition and management of this lesion.
- Introduced and advanced complex coronary intervention strategies in China, including the retrograde guidewire technique for chronic total occlusion, which later became a standard CTO crossing method internationally.
- Led development of China's first biodegradable-polymer drug-eluting coronary stent and the fully bioresorbable XINSORB scaffold platform, linking interventional practice with domestic device innovation.
- Pioneered transradial outpatient coronary angiography and helped establish Shanghai's 24-hour acute myocardial infarction rescue green channel.
Sources — Ge Junbo
- https://zjmz.zs-hospital.sh.cn/menzhen/zjmz.htm—Official Zhongshan Hospital outpatient directory confirming Ge Junbo is currently listed in Cardiology and remains patient-facing(accessed Apr 16, 2026)
- https://shmc.fudan.edu.cn/2021/1130/c1973a117486/page.htm—Official Fudan medical-school profile for identity, CAS academician status, Zhongshan affiliation, research focus, and practice-start timing(accessed Apr 16, 2026)
- https://ibs.fudan.edu.cn/6e/4e/c21166a224846/page.htm—Official Fudan institute profile for date of birth, Mainz doctorate, Essen experience, and current affiliated leadership roles(accessed Apr 16, 2026)
- https://www.haodf.com/doctor/66068/xinxi-jieshao.html—Current professional summary, training chronology, cumulative Haodf patient count, and interventional-cardiology achievements(accessed Apr 16, 2026)
- https://www.parkwaychina.com/medical-teams-303—Current Shanghai Parkway role, language information, and up-to-date public summary of current Zhongshan leadership titles(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/41944160/—Publication verification for coronary intervention microcirculatory resistance study(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/31255452/—Publication verification for XINSORB scaffold outcomes study(accessed Apr 16, 2026)
- https://pubmed.ncbi.nlm.nih.gov/29492775/—Publication verification for XINSORB scaffold imaging outcomes study(accessed Apr 16, 2026)
- https://www.fudan.edu.cn/2021/0526/c24a109048/page.htm—Fudan repost of Wenhui feature supporting pioneering-contribution claims on CTO retrograde technique, biodegradable stents, and Shanghai AMI rescue network(accessed Apr 16, 2026)
Request a case review with Ge Junbo
Ge Junbo practices at Zhongshan Hospital Affiliated to Fudan University in Shanghai.
Request Case Review